Value-based contracts can lower costs for payers, offer pharmaceutical companies valuable feedback about their therapies, and, ultimately, improve the quality of health care.
Jorge E. Galva, JD, MHA, Executive Director at ASES
Advertisement
Articles by Jorge E. Galva, JD, MHA, Executive Director at ASES
Advertisement
Latest Updated Articles
Partnerships Between Medicaid Programs and PBMs Will Shape Future of Health CarePublished: February 1st 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
Experimental Vaccine Shows 73% Efficacy Against Salmonella Paratyphi A
3
Pharmacists Key to Counseling and Monitoring Patients Transitioning to Low-Sodium Oxybate
4
